FDA Inspection 863237 — Biologic Therapy Core Facility, Siteman Cancer Center
The FDA completed an inspection of Biologic Therapy Core Facility, Siteman Cancer Center on Jan 14, 2014 in Saint Louis, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 14, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Saint Louis, MO (United States)